Literature DB >> 27174734

Declining blood collection and utilization in the United States.

Koo-Whang Chung1, Sridhar V Basavaraju1, Yi Mu2, Katharina L van Santen2,3, Kathryn A Haass1,4, Richard Henry5, James Berger5, Matthew J Kuehnert6.   

Abstract

BACKGROUND: The Department of Health and Human Services National Blood Collection and Utilization Survey (NBCUS) has been conducted biennially since 1997. Data are used to estimate national blood collection and utilization. STUDY DESIGN AND METHODS: The 2013 Department of Health and Human Services NBCUS is a cross-sectional survey of all US blood collection centers and hospitals as listed in the 2012 American Hospital Association Annual Survey database that perform at least 100 inpatient surgical procedures annually. The study objective was to estimate, with 95% confidence intervals (CIs), the number of blood and blood components collected and transfused in the United States.
RESULTS: In 2013, a total of 14,237,000 whole blood and apheresis red blood cell (RBC) units (95% CI, 13,639,000-14,835,000) were collected with 13,395,000 available for transfusion. Of these, 13,180,000 (95% CI, 12,389,000-13,972,000) whole blood and RBC units were transfused. This represented a 4.4% decline in the number of transfused units compared to 2011. Outdated (i.e., expired without being transfused) whole blood and RBC units declined by 17.3%. Apheresis (2,318,000; 95% CI, 2,154,000-2,482,000) and whole blood-derived platelet (PLT; 130,000; 95% CI, 23,000-237,000) distribution declined in 2013. Total PLT transfusions increased in 2013 (2,281,000) in comparison to 2011 (2,169,000). Total plasma units distributed (4,338,000) and transfused (3,624,000) declined.
CONCLUSION: Both blood collection and utilization have declined, but the gap between collection and utilization is narrowing. As collections decline further and hospitals decrease transfusions and manage products more efficiently, the decline in surplus inventory may be a concern for disaster preparedness or other unexpected utilization needs.
© 2016 AABB.

Entities:  

Mesh:

Year:  2016        PMID: 27174734      PMCID: PMC5928513          DOI: 10.1111/trf.13644

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  27 in total

1.  The Safety of the Blood Supply--Time to Raise the Bar.

Authors:  Edward L Snyder; Susan L Stramer; Richard J Benjamin
Journal:  N Engl J Med       Date:  2015-08-27       Impact factor: 91.245

Review 2.  Strategies to reduce the use of blood products: a US perspective.

Authors:  Aryeh Shander; Mazyar Javidroozi
Journal:  Curr Opin Anaesthesiol       Date:  2012-02       Impact factor: 2.706

3.  Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012.

Authors:  Alexis R Harvey; Sridhar V Basavaraju; Koo-Whang Chung; Matthew J Kuehnert
Journal:  Transfusion       Date:  2014-11-05       Impact factor: 3.157

4.  Robotic minimally invasive mitral valve reconstruction yields less blood product transfusion and shorter length of stay.

Authors:  Y Joseph Woo; Elliot A Nacke
Journal:  Surgery       Date:  2006-08       Impact factor: 3.982

5.  Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil.

Authors:  Phillip Scheinberg; Olga Nunez; Colin Wu; Neal S Young
Journal:  Br J Haematol       Date:  2006-06       Impact factor: 6.998

6.  Variation in use of blood transfusion in coronary artery bypass graft surgery.

Authors:  Elliott Bennett-Guerrero; Yue Zhao; Sean M O'Brien; T B Ferguson; Eric D Peterson; James S Gammie; Howard K Song
Journal:  JAMA       Date:  2010-10-13       Impact factor: 56.272

7.  Patterns and outcomes of red blood cell transfusion in patients undergoing percutaneous coronary intervention.

Authors:  Matthew W Sherwood; Yongfei Wang; Jeptha P Curtis; Eric D Peterson; Sunil V Rao
Journal:  JAMA       Date:  2014-02-26       Impact factor: 56.272

8.  Collection and transfusion of blood and blood components in the United States, 1994.

Authors:  E L Wallace; W H Churchill; D M Surgenor; G S Cho; S McGurk
Journal:  Transfusion       Date:  1998-07       Impact factor: 3.157

9.  Decreased transfusion requirements in patients given stem cell allografts using a non-myeloablative conditioning regimen: a single institution experience.

Authors:  Guillermo J Ruiz-Argüelles; Briceida López-Martínez; David Gómez-Rangel; Erick Estrada; Antonio Marín-López; Gerardo Bravo-Hernández; Juan Manuel Hernández
Journal:  Hematology       Date:  2003-06       Impact factor: 2.269

Review 10.  Adverse effects of plasma transfusion.

Authors:  Suchitra Pandey; Girish N Vyas
Journal:  Transfusion       Date:  2012-05       Impact factor: 3.157

View more
  32 in total

1.  Sociodemographic and behavioral characteristics associated with blood donation in the United States: a population-based study.

Authors:  Eshan U Patel; Evan M Bloch; Mary K Grabowski; Ruchika Goel; Parvez M Lokhandwala; Patricia A R Brunker; Jodie L White; Beth Shaz; Paul M Ness; Aaron A R Tobian
Journal:  Transfusion       Date:  2019-06-20       Impact factor: 3.157

2.  Is surgical volume still the most accurate indicator of blood usage in the United States?

Authors:  Alexandra Savinkina; Mathew R P Sapiano; James Berger; Sridhar V Basavaraju
Journal:  Transfusion       Date:  2019-02-10       Impact factor: 3.157

Review 3.  Plasma Transfusion Demystified: A Review of the Key Factors Influencing the Response to Plasma Transfusion.

Authors:  Allen W Bryan; Elizabeth M Staley; Timothy Kennell; Alexander Z Feldman; Lance A Williams; Huy P Pham
Journal:  Lab Med       Date:  2017-05-01

4.  Trends in Red Blood Cell, Plasma, and Platelet Transfusions in the United States, 1993-2014.

Authors:  Ruchika Goel; Meera R Chappidi; Eshan U Patel; Paul M Ness; Melissa M Cushing; Steven M Frank; Aaron A R Tobian
Journal:  JAMA       Date:  2018-02-27       Impact factor: 56.272

5.  Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion-related adverse reactions in the United States.

Authors:  Chris Edens; Kathryn A Haass; Melissa Cumming; Anthony Osinski; Lynne O'Hearn; Kelly Passanisi; Lynn Eaton; Paul Visintainer; Alexandra Savinkina; Matthew J Kuehnert; Sridhar V Basavaraju; Chester Andrzejewski
Journal:  Transfusion       Date:  2018-11-14       Impact factor: 3.157

6.  Supplemental findings from the National Blood Collection and Utilization Surveys, 2013 and 2015.

Authors:  Mathew R P Sapiano; Alexandra A Savinkina; Katherine D Ellingson; Kathryn A Haass; Misha L Baker; Richard A Henry; James J Berger; Matthew J Kuehnert; Sridhar V Basavaraju
Journal:  Transfusion       Date:  2017-06       Impact factor: 3.157

7.  Continued decline in blood collection and transfusion in the United States-2015.

Authors:  Katherine D Ellingson; Mathew R P Sapiano; Kathryn A Haass; Alexandra A Savinkina; Misha L Baker; Koo-Whang Chung; Richard A Henry; James J Berger; Matthew J Kuehnert; Sridhar V Basavaraju
Journal:  Transfusion       Date:  2017-06       Impact factor: 3.157

8.  Factors associated with red blood cell, platelet, and plasma transfusions among inpatient hospitalizations: a nationally representative study in the United States.

Authors:  Ruchika Goel; Eshan U Patel; Jodie L White; Meera R Chappidi; Paul M Ness; Melissa M Cushing; Clifford M Takemoto; Beth H Shaz; Steven M Frank; Aaron A R Tobian
Journal:  Transfusion       Date:  2018-12-12       Impact factor: 3.157

9.  Individual- and hospital-level correlates of red blood cell, platelet, and plasma transfusions among hospitalized children and neonates: a nationally representative study in the United States.

Authors:  Ruchika Goel; Cassandra D Josephson; Eshan U Patel; Molly R Petersen; Zoe Packman; Eric Gehrie; Evan M Bloch; Parvez Lokhandwala; Paul M Ness; Louis Katz; Marianne Nellis; Oliver Karam; Aaron A R Tobian
Journal:  Transfusion       Date:  2020-06-26       Impact factor: 3.157

10.  Analysis of a large data set to identify predictors of blood transfusion in primary total hip and knee arthroplasty.

Authors:  ZeYu Huang; Cheng Huang; JinWei Xie; Jun Ma; GuoRui Cao; Qiang Huang; Bin Shen; Virginia Byers Kraus; FuXing Pei
Journal:  Transfusion       Date:  2018-08-25       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.